Summary & Overview
HCPCS A2039: Innovamatrix fd, Per Square Centimeter (Add-On)
HCPCS Level II code A2039 designates Innovamatrix fd, billed per square centimeter as an add-on to a primary procedure. It is used for billing topical graft or matrix products applied to wounds or surgical sites, where payment is calculated by area treated. Nationally, accurate use of HCPCS Level II code A2039 matters for proper claims submission, product-level tracking, and alignment with payer coverage policies for graft substitutes and topical biologic matrices.
Key payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of payer coverage considerations, common billing modifiers and coding context, and expected service settings. The publication summarizes benchmark pricing approaches, coding compliance considerations for add-on product billing, and practical clinical context where a per-square-centimeter product is applied. It also highlights areas where policy clarification from payers may affect claim acceptance and documentation expectations.
This resource is intended for billing managers, coding professionals, and clinicians responsible for submitting claims involving topical matrix products billed as add-on services.
Billing Code Overview
HCPCS Level II code A2039 describes Innovamatrix fd, billed per square centimeter as an add-on, list separately in addition to primary procedure. This code represents a topical or local graft/substance product applied to a wound or surgical site where billing is calculated by surface area.
Service Type: Wound care product application / topical graft substitute
Typical Site of Service: Outpatient clinic, hospital outpatient department, ambulatory surgical center, or other settings where a primary procedure addressing a wound or surgical site is performed
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with a full-thickness or partial-thickness skin loss following trauma, surgical excision of a chronic wound or necrotic tissue, or a non-healing ulcer (e.g., diabetic foot ulcer, venous stasis ulcer). The clinician prepares the wound by debridement and hemostasis in an outpatient procedure room or ambulatory surgical center, then applies a biologic matrix dressing — billed using A2039 per square centimeter as an add-on material charge. The workflow includes wound assessment, sterile preparation, measurement of defect size to determine square centimeters of product used, application of the Innovamatrix FD product to the wound bed, securement with a secondary dressing, and patient/caregiver instructions for wound care and follow-up. Typical sites of service are outpatient wound clinics, physician offices with procedure capability, hospital outpatient departments, and ambulatory surgical centers. Common clinical teams include wound care specialists, general surgeons, plastic surgeons, podiatrists, and advanced practice providers overseeing dressing application and follow-up care.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier — standard use | Use when no special circumstances or ownership/loaned items apply and the service is standard. |